Anchiano Enters an Exclusive Option Agreement to License Novel Pan-RAS Inhibitor and PDE10/β-catenin Inhibitor Programs – CBI
Homepage /  Press Release /  Anchiano Enters an Exclusive Option Agreement to License Novel Pan-RAS Inhibitor and PDE10/β-catenin Inhibitor Programs

Press Release

Anchiano Enters an Exclusive Option Agreement to License Novel Pan-RAS Inhibitor and PDE10/β-catenin Inhibitor Programs